Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site

The peripheral anionic site on acetylcholinesterase (AChE), located at the active center gorge entry, encompasses overlapping binding sites for allosteric activators and inhibitors; yet, the molecular mechanisms coupling this site to the active center at the gorge base to modulate catalysis remain unclear. The peripheral site has also been proposed to be involved in heterologous protein associations occurring during synaptogenesis or upon neurodegeneration. A novel crystal form of mouse AChE, combined with spectrophotometric analyses of the crystals, enabled us to solve unique structures of AChE with a free peripheral site, and as three complexes with peripheral site inhibitors: the phenylphenanthridinium ligands, decidium and propidium, and the pyrogallol ligand, gallamine, at 2.20–2.35 Å resolution. Comparison with structures of AChE complexes with the peptide fasciculin or with organic bifunctional inhibitors unveils new structural determinants contributing to ligand interactions at the peripheral site, and permits a detailed topographic delineation of this site. Hence, these structures provide templates for designing compounds directed to the enzyme surface that modulate specific surface interactions controlling catalytic activity and non‐catalytic heterologous protein associations.

[1]  N. Inestrosa,et al.  Thioflavin T Is a Fluorescent Probe of the Acetylcholinesterase Peripheral Site That Reveals Conformational Interactions between the Peripheral and Acylation Sites* , 2001, The Journal of Biological Chemistry.

[2]  J. Sussman,et al.  Relationship between sequence conservation and three‐dimensional structure in a large family of esterases, lipases, and related proteins , 1993, Protein science : a publication of the Protein Society.

[3]  T. Rosenberry,et al.  Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands. , 1998, Biochemistry.

[4]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[5]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[6]  L. R. Scott,et al.  Computer Modeling of Acetylcholinesterase and Acetylcholinesterase-Ligand Complexes , 1995 .

[7]  P. Taylor,et al.  Expression and Activity of Mutants of Fasciculin, a Peptidic Acetylcholinesterase Inhibitor from Mamba Venom* , 1997, The Journal of Biological Chemistry.

[8]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[9]  P Taylor,et al.  The cholinesterases: from genes to proteins. , 1994, Annual review of pharmacology and toxicology.

[10]  J. Changeux,et al.  Responses of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs. , 1966, Molecular pharmacology.

[11]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[12]  J C Fontecilla-Camps,et al.  1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom. , 1993, The Journal of biological chemistry.

[13]  B. Roufogalis,et al.  Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase. , 1972, Molecular Pharmacology.

[14]  P. Taylor,et al.  Ligand-induced conformational changes in acetylcholinesterase investigated with fluorescent phosphonates. , 1979, Biochemistry.

[15]  B. Robaire,et al.  Effects of Mg2+ and Ca2+ on soluble and membrane-bound acetylcholinesterase from Electrophorus electricus. , 1974, Biochemical pharmacology.

[16]  J L Sussman,et al.  Soluble monomeric acetylcholinesterase from mouse: Expression, purification, and crystallization in complex with fasciculin , 1996, Protein science : a publication of the Protein Society.

[17]  Y. Li,et al.  Molecular cloning of mouse acetylcholinesterase: Tissue distribution of alternatively spliced mRNA species , 1990, Neuron.

[18]  Palmer Taylor,et al.  Enzymes of the Cholinesterase Family , 1995, Springer US.

[19]  P. Taylor,et al.  Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. , 1991, Molecular pharmacology.

[20]  P. Taylor,et al.  Reversibly Bound and Covalently Attached Ligands Induce Conformational Changes in the Omega Loop, Cys69–Cys96, of Mouse Acetylcholinesterase* , 2001, The Journal of Biological Chemistry.

[21]  Z. Dauter,et al.  Entering a new phase: using solvent halide ions in protein structure determination. , 2001, Structure.

[22]  P Taylor,et al.  Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. , 1993, Biochemistry.

[23]  Claudia Linker,et al.  Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.

[24]  P. Taylor,et al.  Fluorescence energy transfer on acetylcholinesterase: spatial relationship between peripheral site and active center. , 1980, Biochemistry.

[25]  P. Taylor,et al.  Site selectivity of fluorescent bisquaternary phenanthridinium ligands for acetylcholinesterase. , 1987, Molecular pharmacology.

[26]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[27]  J L Sussman,et al.  Structure of acetylcholinesterase complexed with (−)‐galanthamine at 2.3 Å resolution , 1999, FEBS letters.

[28]  J. Sussman,et al.  Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase. , 1994, Molecular pharmacology.

[29]  N. Ariel,et al.  Contribution of Aromatic Moieties of Tyrosine 133 and of the Anionic Subsite Tryptophan 86 to Catalytic Efficiency and Allosteric Modulation of Acetylcholinesterase (*) , 1995, The Journal of Biological Chemistry.

[30]  P. Taylor,et al.  Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. , 2002, Angewandte Chemie.

[31]  H. Berman,et al.  Kinetic, equilibrium and spectroscopic studies on cation association at the active center of acetylcholinesterase: topographic distinction between trimethyl and trimethylammonium sites. , 1986, Biochimica et biophysica acta.

[32]  G. Kleywegt,et al.  Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target. , 1995, Structure.

[33]  C. Bartolucci,et al.  "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase. , 1999, Biochemistry.

[34]  P. Taylor,et al.  Allosteric Control of Acetylcholinesterase Catalysis by Fasciculin (*) , 1995, The Journal of Biological Chemistry.

[35]  E. Karlsson,et al.  Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps. , 1984, Journal de physiologie.

[36]  P. Taylor,et al.  Spectroscopic studies on acetylcholinesterase: influence of peripheral-site occupation on active-center conformation. , 1981, Biochemistry.

[37]  T. Rosenberry,et al.  Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway. , 2000, Biochemistry.

[38]  J. Sussman,et al.  Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase. , 2002, Acta crystallographica. Section D, Biological crystallography.

[39]  J. Sussman,et al.  Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica. , 2000, Journal of molecular biology.

[40]  J. Sussman,et al.  Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. P. Doctor,et al.  Different effects of two peripheral anionic site-binding ligands on acetylcholinesterase active-site gorge topography revealed by electron paramagnetic resonance. , 1995, Biochimica et biophysica acta.

[42]  Yuan-Ping Pang,et al.  Structure of acetylcholinesterase complexed with the nootropic alkaloid, (–)-huperzine A , 1997, Nature Structural Biology.

[43]  N. Ariel,et al.  Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. , 1992, The EMBO journal.

[44]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[45]  Palmer Taylor,et al.  Inhibitors of Different Structure Induce Distinguishing Conformations in the Omega Loop, Cys69–Cys96, of Mouse Acetylcholinesterase* , 2002, The Journal of Biological Chemistry.

[46]  P. Taylor,et al.  Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex , 1995, Cell.

[47]  S. Moore,et al.  The adhesion function on acetylcholinesterase is located at the peripheral anionic site. , 1999, Biochemical and biophysical research communications.

[48]  H. Soreq,et al.  Acetylcholinesterase — new roles for an old actor , 2001, Nature Reviews Neuroscience.

[49]  Yong-hua Ji,et al.  Binding of 125I-fasciculin to rat brain acetylcholinesterase. The complex still binds diisopropyl fluorophosphate. , 1993, The Journal of biological chemistry.

[50]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[51]  T L Rosenberry,et al.  Fasciculin 2 Binds to the Peripheral Site on Acetylcholinesterase and Inhibits Substrate Hydrolysis by Slowing a Step Involving Proton Transfer during Enzyme Acylation (*) , 1995, The Journal of Biological Chemistry.

[52]  Z. Radić,et al.  Peripheral site ligands accelerate inhibition of acetylcholinesterase by neutral organophosphates , 2001, Journal of applied toxicology : JAT.

[53]  F. Vallette,et al.  Molecular and cellular biology of cholinesterases , 1993, Progress in Neurobiology.

[54]  P Taylor,et al.  Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. , 1975, Biochemistry.

[55]  N. Ariel,et al.  Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. , 1994, The Journal of biological chemistry.

[56]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[57]  N. Ariel,et al.  Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. , 2000, Acta crystallographica. Section D, Biological crystallography.

[58]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.

[59]  N. Ariel,et al.  Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. , 1995, Biochemistry.